Table 3 Peripheral neuropathy and sensitivity (n = 117)

Symptoms

88 (75,2)

67,0–83,5

Tingling/Crawling sensation

65 (56,0)

46,1–65,0

Abrasion

8 (6,8)

1,8–11,8

Needles

23 (19,7)

12,0–27,3

Imbalance

9 (7,7)

2,4–12,9

Numbness, lack of sensitivity

17 (14,5)

7,7–21,3

Muscular weakness

18 (15,4)

8,4–22,3

Pins

15 (12,8)

6,3–19,3

Muscle and joint stiffness

30 (25,6)

16,5–33,0

Dysesthesia-Paraesthesia

20 (17,1)

9,8–24,3

WHO Peripheral Neuropathy Scale

 No symptoms

29 (24,8)

18,8–35,8

 Paraesthesia or weakness without pain or loss of function

25 (21,4)

9,1–23,3

 Pain that interferes with function, but not with ADLs

45 (38,8)

29,2–47,7

 Pain that interferes with ADLs

17 (14,5)

7,7–21,3

 Motor affectation and/or disabling pain

1 (0,9)

0,02–4,7

HFS Study Degree

 WHO HFS Scale

  Grade 1

6 (14,3)

2,5–26,1

  Grade 2

10 (23,8)

9,7–37,9

  Grade 3

14 (33,3)

17,9–48,8

  Grade 4

12 (28,6)

13,7–43,4

NCI HFS Scale

 Grade 1

6 (14,3)

2,5–26,1

 Grade 2

16 (38,1)

22,2–54,0

 Grade 3

20 (47,6)

31,3–63,9

Sensitivity assessment using monofilament

 First Toe

30 (25,9)

17,3–34,0

 First Metatarsal Head

29 (25,0)

16,5–33,0

 Third Metatarsal Head

29 (25,0)

16,5–33,0

 Fifth Metatarsal Head

26 (22,4)

14,3–30,2